Literature DB >> 11937488

A molecular link between gene-specific and chromosome-wide transcriptional repression.

Diana S Chu1, Heather E Dawes, Jason D Lieb, Raymond C Chan, Annie F Kuo, Barbara J Meyer.   

Abstract

Gene-specific and chromosome-wide mechanisms of transcriptional regulation control development in multicellular organisms. SDC-2, the determinant of hermaphrodite fate in Caenorhabditis elegans, is a paradigm for both modes of regulation. SDC-2 represses transcription of X chromosomes to achieve dosage compensation, and it also represses the male sex-determination gene her-1 to elicit hermaphrodite differentiation. We show here that SDC-2 recruits the entire dosage compensation complex to her-1, directing this X-chromosome repression machinery to silence an individual, autosomal gene. Functional dissection of her-1 in vivo revealed DNA recognition elements required for SDC-2 binding, recruitment of the dosage compensation complex, and transcriptional repression. Elements within her-1 differed in location, sequence, and strength of repression, implying that the dosage compensation complex may regulate transcription along the X chromosome using diverse recognition elements that play distinct roles in repression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11937488      PMCID: PMC186330          DOI: 10.1101/gad.972702

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  31 in total

1.  Early aspects of Caenorhabditis elegans sex determination and dosage compensation are regulated by a zinc-finger protein.

Authors:  M L Nonet; B J Meyer
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

2.  Sex-specific transcriptional regulation of the C. elegans sex-determining gene her-1.

Authors:  C Trent; B Purnell; S Gavinski; J Hageman; C Chamblin; W B Wood
Journal:  Mech Dev       Date:  1991-03       Impact factor: 1.882

3.  The Caenorhabditis elegans gene sdc-2 controls sex determination and dosage compensation in XX animals.

Authors:  C Nusbaum; B J Meyer
Journal:  Genetics       Date:  1989-07       Impact factor: 4.562

4.  Molecular characterization of the her-1 gene suggests a direct role in cell signaling during Caenorhabditis elegans sex determination.

Authors:  M D Perry; W Li; C Trent; B Robertson; A Fire; J M Hageman; W B Wood
Journal:  Genes Dev       Date:  1993-02       Impact factor: 11.361

5.  Feedback control of sex determination by dosage compensation revealed through Caenorhabditis elegans sdc-3 mutations.

Authors:  L DeLong; J D Plenefisch; R D Klein; B J Meyer
Journal:  Genetics       Date:  1993-04       Impact factor: 4.562

6.  Independent domains of the Sdc-3 protein control sex determination and dosage compensation in C. elegans.

Authors:  R D Klein; B J Meyer
Journal:  Cell       Date:  1993-02-12       Impact factor: 41.582

7.  Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae.

Authors:  O M Aparicio; B L Billington; D E Gottschling
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

8.  The role of sdc-1 in the sex determination and dosage compensation decisions in Caenorhabditis elegans.

Authors:  A M Villeneuve; B J Meyer
Journal:  Genetics       Date:  1990-01       Impact factor: 4.562

9.  A novel dominant transformer allele of the sex-determining gene her-1 of Caenorhabditis elegans.

Authors:  C Trent; W B Wood; H R Horvitz
Journal:  Genetics       Date:  1988-09       Impact factor: 4.562

10.  Primary sex determination in the nematode C. elegans.

Authors:  J Hodgkin
Journal:  Development       Date:  1987       Impact factor: 6.868

View more
  35 in total

1.  Balance between acetylation and methylation of histone H3 lysine 9 on the E2F-responsive dihydrofolate reductase promoter.

Authors:  Estelle Nicolas; Christine Roumillac; Didier Trouche
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

Review 2.  Condensin and cohesin complexity: the expanding repertoire of functions.

Authors:  Andrew J Wood; Aaron F Severson; Barbara J Meyer
Journal:  Nat Rev Genet       Date:  2010-05-05       Impact factor: 53.242

3.  X chromosome repression by localization of the C. elegans dosage compensation machinery to sites of transcription initiation.

Authors:  Sevinc Ercan; Paul G Giresi; Christina M Whittle; Xinmin Zhang; Roland D Green; Jason D Lieb
Journal:  Nat Genet       Date:  2007-02-11       Impact factor: 38.330

4.  Revisiting the X:A signal that specifies Caenorhabditis elegans sexual fate.

Authors:  John M Gladden; Behnom Farboud; Barbara J Meyer
Journal:  Genetics       Date:  2007-10-18       Impact factor: 4.562

5.  A ONECUT homeodomain protein communicates X chromosome dose to specify Caenorhabditis elegans sexual fate by repressing a sex switch gene.

Authors:  John M Gladden; Barbara J Meyer
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

Review 6.  C. elegans dosage compensation: a window into mechanisms of domain-scale gene regulation.

Authors:  Sevinc Ercan; Jason D Lieb
Journal:  Chromosome Res       Date:  2009       Impact factor: 5.239

7.  Untangling the Contributions of Sex-Specific Gene Regulation and X-Chromosome Dosage to Sex-Biased Gene Expression in Caenorhabditis elegans.

Authors:  Maxwell Kramer; Prashant Rao; Sevinc Ercan
Journal:  Genetics       Date:  2016-06-29       Impact factor: 4.562

8.  Transcriptional silencing of a transgene by RNAi in the soma of C. elegans.

Authors:  Alla Grishok; Jina L Sinskey; Phillip A Sharp
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

9.  RNAi pathways contribute to developmental history-dependent phenotypic plasticity in C. elegans.

Authors:  Sarah E Hall; Gung-Wei Chirn; Nelson C Lau; Piali Sengupta
Journal:  RNA       Date:  2013-01-17       Impact factor: 4.942

10.  xol-1, the master sex-switch gene in C. elegans, is a transcriptional target of the terminal sex-determining factor TRA-1.

Authors:  Balázs Hargitai; Vera Kutnyánszky; Timothy A Blauwkamp; Attila Steták; Györgyi Csankovszki; Krisztina Takács-Vellai; Tibor Vellai
Journal:  Development       Date:  2009-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.